BNR
Burning Rock Biotech
$9.40
+$0.45 (+5.03%)Jul 27, 2026
Key metrics
The numbers that frame BNR today
- Market cap
- $98.88M
- P/E (TTM)
- -11.3
- EV / FCF
- -7.1
- Gross margin
- 74.6%
- EV / Sales
- 0.5
- ROIC
- -37.4%
- Div yield
- 0%
- Debt / equity
- 0.1
- 52wk Low
- $5.31
- 52wk High
- $41.72
Growth
Revenue and earnings trend for BNR
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about BNR
Is Burning Rock Biotech a good buy?
Hold. Burning Rock Biotech has excellent quality, but poor momentum makes the setup mixed. Growth looks poor. That could put pressure on the long-term business case. We think Burning Rock Biotech is selling at a very high price.
What is the market capitalization of BNR?
Burning Rock Biotech's market capitalization is $98.88M.
What is the P/E ratio for BNR stock?
Burning Rock Biotech's current P/E ratio is -11.3.
What is the 52-week high for BNR stock?
The 52-week high for Burning Rock Biotech is $41.72. The current close of $9.40 is 77.5% below that high.
What is the 52-week low for BNR stock?
The 52-week low for Burning Rock Biotech is $5.31. The current close of $9.40 is 77% above that low.
Does BNR stock pay dividends?
Burning Rock Biotech does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for BNR?
Burning Rock Biotech's Debt / Equity ratio is 0.1.